{"id":"W2267782951","doi":"10.1111/apt.13519","title":"Editorial: fenofibrate as second‐line therapy in high risk <scp>PBC</scp> – more answers or more questions? Authors' reply","year":2016,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre for Global Health Research; Public Health Ontario; University of Toronto; University Health Network","funders":"Pfizer","keywords":"Fenofibrate; Medicine; Internal medicine; First line therapy; Line (geometry)","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004781425,0.002586526,0.002597794,0.001809002,0.002163616,0.003459433,0.00295374,0.01588082,0.01130073],"category_scores_gemma":[0.02013559,0.0009471555,0.002136683,0.000782259,0.001727293,0.003268582,0.0008009197,0.02019797,0.01198007],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002266743,"about_ca_system_score_gemma":0.002187852,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001252486,"about_ca_topic_score_gemma":0.002637434,"domain_scores_codex":[0.9971807,0.0005015152,0.0004482407,0.0003641265,0.00126506,0.0002404096],"domain_scores_gemma":[0.9902591,0.003794034,0.0006284808,0.0002524546,0.003681987,0.001384001],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005401637,0.0000151787,0.00003902523,0.000108824,0.000018246,0.0001780587,0.00001025887,0.00002217589,0.00005326151,0.0001573452,0.9963219,0.003021666],"study_design_scores_gemma":[0.0002046274,0.0000892559,0.0005462787,0.0005442864,0.00011995,0.001182229,0.00006718275,0.0002707614,0.0003440959,0.001261534,0.9953268,0.00004298486],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"editorial","genre_scores_codex":[0.000114271,0.00356906,0.0001533292,0.1489227,0.8453587,0.00002927377,0.0001070259,0.00009041635,0.001655159],"genre_scores_gemma":[0.001090419,0.003533358,0.0001760407,0.1503106,0.8353814,0.00003873604,0.00006312383,0.00005656474,0.009349665],"genre_candidate":"editorial","genre_consensus":"editorial","teacher_disagreement_score":0.01588082,"threshold_uncertainty_score":0.03780466,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0193109503257304,"score_gpt":0.3471324163951592,"score_spread":0.3278214660694289,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}